AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 22 min read$BWXT

Earnings To Watch: BWX (BWXT) Reports Q2 Results Tomorrow

BWX Technologies (NYSE: BWXT) is set to report Q2 earnings Monday afternoon. Last quarter, it reported revenue of $860.2 million, up 26.1% year over year, and beat analysts’ revenue, EBITDA, and EPS estimates. For the upcoming quarter, analysts expect revenue growth of 18.3% y/y. The article cites an average price target of $238.16 versus $168.79.

Original reporting
financialcontent.com
Published Aug 2, 2026, 4:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 2, 2026, 5:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Earnings To Watch: BWX (BWXT) Reports Q2 Results Tomorrow — source image
Source · financialcontent.com
Decision brief

The 30-second read

$BWXTNeutralMed
01

Why it matters

Traders can use the provided consensus revenue growth (18.3% YoY) and the stock’s recent underperformance (down 14.2% over the last year period cited) to position for earnings volatility, but there is no new fundamental disclosure in the text.

02

Market read

Earnings preview for BWXT with consensus revenue growth and peer read-through, useful for near-term positioning into the release.

03

What to watch

The preview omits key items traders usually anchor on (segment margins, backlog/bookings, cash flow, and updated guidance), so the setup may understate downside risk.

Relevance 4/10Novelty 3/10Timing: ahead of Monday afternoon earnings release

Background

BWXT previously beat revenue, EBITDA, and EPS expectations last quarter, and the article frames this as a repeatable pattern.

Company-level read

Ticker impact

$BWXTNeutralMedium confidence
Context

BWXT is scheduled to report Q2 results Monday afternoon, with consensus revenue growth expected at 18.3% YoY.

Expected impact

Near-term volatility likely around the Q2 release versus the 18.3% YoY revenue expectation and prior beat history.

Evidence & confidence

The article provides expectations (revenue growth, reconfirmed estimates) and prior beat framing, but no new company-specific disclosure beyond the timing of the report.

Market effects

Sector

Defense contractor earnings season context is referenced via peers, but without new guidance changes from BWXT.

Regional

None specified.

Global

None specified.

Counterpoint

What could challenge this read

Even with reconfirmed estimates, defense names can trade down if margins, backlog, or guidance disappoint versus the market’s geopolitical and rates narrative.

Key entities

  • company
    BWX Technologies

    BWXT, the subject company scheduled to report Q2 results Monday afternoon.

  • company
    Huntington Ingalls

    Peer cited as having reported Q2 revenue growth of 10.9% and a post-results stock move.

  • company
    RTX

    Peer cited as having reported Q2 revenues up 14.5% and a post-results stock move.

Read at source← All news

Related articles

AUG 6
$BWXTMed

BWXT expands U.S. naval nuclear manufacturing base through PCG acquisition, targeting capacity and supply-chain gains for Navy programs

BWXT said it completed its early-July acquisition of PCG, expanding its U.S. naval nuclear manufacturing base. BWXT’s CEO Rex Geveden said most PCG revenue and backlog supports the U.S. Naval Nuclear Propulsion Program. BWXT plans integration over coming quarters, assessing which outsourced work to bring in-house and potential capital needs, with PCG focused on medium-scale components.

defence-industry.eu4 min
AUG 4
$BWXTMedAI 8/10

Sweden: Nordic Capital to acquire majority stake in BWXT’s medical business

BWX Technologies (NYSE: BWXT) will sell its medical business, including BWXT Medical and Kinectrics’ stable medical isotopes unit, to Sweden-based Nordic Capital for up to $800m. BWXT will keep a minority stake and continue providing isotope and radiochemical expertise. BWXT said the business tripled revenue since 2018; Nordic Capital plans to scale radiopharmaceuticals.

investorsinhealthcare.com3 min
AUG 3
$BWXTHighAI 9/10

BWX Technologies, Inc. (BWXT): Results of Operations and Financial Condition

BWX Technologies, Inc. (BWXT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bwxt_63026xerexhibit991.htm EX-99.1 Document BWX Technologies Reports Second Quarter 2026 Results • 2Q26 revenues of $901.6 million • 2Q26 net income of $89.1 million, adjusted EBITDA (1) of $155.5 million • 2Q26 diluted GAAP EPS of $0.97, non-GAAP (1) EPS of $1.07 • An

SEC EDGAR 8-K7 min
AUG 1
$BWXTMed

JPMorgan makes bold BWX Technologies prediction

JPMorgan began coverage of BWX Technologies (BWXT) on July 27, 2026 with an Overweight rating and a $230 price target through Dec 2027. The target is about 30% above the stock’s July 28 close of $169.67. JPMorgan cites BWXT’s U.S. Navy reactor-core work, $1.4B in new Navy contracts in May, and Q1 FY2026 results: $860.2M revenue (+26% YoY) and $1.12 adjusted EPS.

yahoo.com6 min